Gossamer Bio
GOSS
GOSS
141 hedge funds and large institutions have $520M invested in Gossamer Bio in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.38% more ownership
Funds ownership: 76.92% → 78.3% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
22% less capital invested
Capital invested by funds: $664M → $520M (-$144M)
Holders
141
Holding in Top 10
3
Calls
$13M
Puts
$4.76M
Top Buyers
| 1 | +$9.11M | |
| 2 | +$7.08M | |
| 3 | +$4.9M | |
| 4 |
EP
Eversept Partners
New York
|
+$2.91M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.33M |
Top Sellers
| 1 | -$7.72M | |
| 2 | -$5.85M | |
| 3 | -$4.41M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3.4M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$3.01M |